Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
triamcinolone (kenalog) (1 trial)
Coronary Disease (Phase 2)
Infarction (Phase 2)
Ischemia (Phase 2)
Myocardial Infarction (Phase 2)
Myocardial Ischemia (Phase 2)
Reperfusion Injury (Phase 2)
Trials (1 total)
Trial APIs (1 total)